AR038628A1 - Composicion oftalmica - Google Patents

Composicion oftalmica

Info

Publication number
AR038628A1
AR038628A1 ARP030100667A ARP030100667A AR038628A1 AR 038628 A1 AR038628 A1 AR 038628A1 AR P030100667 A ARP030100667 A AR P030100667A AR P030100667 A ARP030100667 A AR P030100667A AR 038628 A1 AR038628 A1 AR 038628A1
Authority
AR
Argentina
Prior art keywords
ascomycin
composition
ophthalm
blepharitis
epi
Prior art date
Application number
ARP030100667A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR038628(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR038628A1 publication Critical patent/AR038628A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Composiciones oftálmicas tópicas, las cuales comprenden una ascomicina, por ejemplo, para el tratamiento de enfermedades inflamatorias, tales como blefaritis. Reivindicación 1: Una composición oftálmica, la cual comprende una ascomicina y un vehículo, el cual comprende un triglicérido de cadena mediana y/o miristato de isopropilo. Reivindicación 2: La composición de acuerdo con la reivindicación 1, en donde la ascomicina es 33-epi-cloro-33-desoxi-ascomicina.
ARP030100667A 2002-03-04 2003-02-28 Composicion oftalmica AR038628A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09

Publications (1)

Publication Number Publication Date
AR038628A1 true AR038628A1 (es) 2005-01-19

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100667A AR038628A1 (es) 2002-03-04 2003-02-28 Composicion oftalmica

Country Status (28)

Country Link
US (4) US20050220823A1 (es)
EP (1) EP1482936B1 (es)
JP (1) JP4740542B2 (es)
KR (1) KR100992948B1 (es)
CN (1) CN1297270C (es)
AR (1) AR038628A1 (es)
AT (1) ATE341326T1 (es)
AU (1) AU2003218679B2 (es)
BR (1) BR0308184A (es)
CA (1) CA2477769C (es)
CO (1) CO5611133A2 (es)
DE (1) DE60308836T2 (es)
DK (1) DK1482936T3 (es)
EC (1) ECSP045277A (es)
EG (1) EG24403A (es)
ES (1) ES2274214T3 (es)
HK (1) HK1071301A1 (es)
IL (2) IL163657A0 (es)
MX (1) MXPA04008571A (es)
MY (1) MY137563A (es)
NO (1) NO20044092L (es)
NZ (1) NZ534690A (es)
PE (1) PE20030828A1 (es)
PL (1) PL210870B1 (es)
PT (1) PT1482936E (es)
RU (1) RU2322982C2 (es)
TW (1) TW200305437A (es)
WO (1) WO2003074054A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0312635A (pt) 2002-07-15 2005-04-19 Alcon Inc Composições de implante farmacêutico lipofìlico não polimérico para uso intraocular
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en) 2009-04-09 2010-10-13 Nestec S.A. Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
MX345888B (es) 2009-05-12 2017-02-22 Galenica Ab * Emulsion aceite en agua de mometasona y propilenglicol.
KR20120098915A (ko) * 2009-12-22 2012-09-05 아보트 러보러터리즈 Ａｂｔ?２６３ 캡슐제
US20110251285A1 (en) * 2010-04-07 2011-10-13 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
RU2531937C2 (ru) * 2012-05-14 2014-10-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
US20160074321A1 (en) * 2013-03-27 2016-03-17 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
CN105792848B (zh) * 2013-11-29 2021-04-09 乐敦制药株式会社 眼科用或耳鼻科用水性组合物
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066915T3 (es) * 1989-07-05 1995-03-16 Fujisawa Pharmaceutical Co Composicion liquida acuosa para uso externo.
DK0474126T3 (es) * 1990-09-04 1997-04-07 Fujisawa Pharmaceutical Co
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
DE69328368T2 (de) * 1992-08-28 2000-08-10 Pharmos Corp Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
WO1995005176A1 (en) * 1993-08-18 1995-02-23 Alcon Laboratories, Inc. Use of ergoline derivatives for the treatment of glaucoma
US5891913A (en) * 1994-10-10 1999-04-06 Novartis Finance Corporation Ophthalmic and aural compositions containing diclofenac potassium
AU714254B2 (en) * 1994-10-26 1999-12-23 Novartis Ag Pharmaceutical compositions
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
JP3732525B2 (ja) * 1998-04-27 2006-01-05 アステラス製薬株式会社 医薬組成物
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
CA2372448A1 (en) * 1999-04-30 2000-11-09 Sucampo Ag Use of macrolide compounds for the treatment of dry eye

Also Published As

Publication number Publication date
JP4740542B2 (ja) 2011-08-03
WO2003074054A1 (en) 2003-09-12
CA2477769C (en) 2011-01-18
PL210870B1 (pl) 2012-03-30
AU2003218679B2 (en) 2007-04-05
KR100992948B1 (ko) 2010-11-08
JP2005529851A (ja) 2005-10-06
PL370917A1 (en) 2005-06-13
KR20040094718A (ko) 2004-11-10
HK1071301A1 (en) 2005-07-15
CN1297270C (zh) 2007-01-31
US20120015971A1 (en) 2012-01-19
NZ534690A (en) 2007-06-29
EG24403A (en) 2009-04-29
ATE341326T1 (de) 2006-10-15
DE60308836T2 (de) 2007-04-26
BR0308184A (pt) 2005-01-11
IL163657A0 (en) 2005-12-18
US20100113501A1 (en) 2010-05-06
PE20030828A1 (es) 2003-11-04
CO5611133A2 (es) 2006-02-28
NO20044092L (no) 2004-09-27
MY137563A (en) 2009-02-27
IL163657A (en) 2009-11-18
DE60308836D1 (de) 2006-11-16
US20050220823A1 (en) 2005-10-06
CA2477769A1 (en) 2003-09-12
RU2322982C2 (ru) 2008-04-27
RU2004129593A (ru) 2005-09-10
CN1638769A (zh) 2005-07-13
DK1482936T3 (da) 2007-01-08
EP1482936B1 (en) 2006-10-04
MXPA04008571A (es) 2004-12-06
AU2003218679A1 (en) 2003-09-16
US20110152307A1 (en) 2011-06-23
EP1482936A1 (en) 2004-12-08
TW200305437A (en) 2003-11-01
ECSP045277A (es) 2004-10-26
ES2274214T3 (es) 2007-05-16
PT1482936E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
AR038628A1 (es) Composicion oftalmica
ECSP066972A (es) Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos
UY28222A1 (es) Inhibidores de citoquinas
ES2183937T3 (es) Inhibidores de la adhesion celular.
GT200100151A (es) Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-dione como inhibidores de glucogeno sintasa quinasa-3b.
PA8544901A1 (es) Derivados de oxazol
CL2010001486A1 (es) Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak; composicion farmaceutica; kit farmaceutico; su uso en el tratamiento de enfermedades tales como cancer, diabetes, enfermedad de alzheimer, enfermedad hepatica, trastornos del snc, entre otras.
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
CO6440524A2 (es) Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la quinasa janus.
HRP20040917B1 (hr) Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
ECSP055844A (es) Nuevos compuestos triciclicos
HN2001000019A (es) Derivados de nicotinamida benzocondensada heterociclico utiles como inhibidores selectivos de las isozimas pde4.
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
PA8550101A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células, y métodos para su utilización
UY27924A1 (es) Compuestos tipo diarilureas fluoradas
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
EA200501399A1 (ru) Производные бензопирана, которые могут использоваться при лечении воспалительных заболеваний
UY29239A1 (es) Nuevos derivados de piridotienopirimidina
EA200700044A1 (ru) Композиция для местного применения
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades

Legal Events

Date Code Title Description
FB Suspension of granting procedure